top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Botulinum Neurotoxins and Nervous System : Future Challenges for Novel Indications
Botulinum Neurotoxins and Nervous System : Future Challenges for Novel Indications
Autore Luvisetto Siro
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (368 p.)
Soggetto topico Medicine
Soggetto non controllato botulinum toxin
limb tremors
muscle selection
biological effect
various cell types
neurotransmitter
dermatology
novel indication
botulinum neurotoxin
masticatory system
maxillofacial bone
dental occlusion
orthognathic surgery
sialorrhoea
drooling
salivary glands
swallowing
eccrine glands
onabotulinumtoxin A
incobotulinumtoxin A
botulinum neurotoxins
botulinum neurotoxin serotype A
heavy chain
botulinum neurotoxin serotype a heavy chain (BoNT/A HC)
spinal cord injury (SCI)
nerve regeneration
growth associated protein 43 (GAP-43)
superior cervical ganglion 10 (SCG10)
neuronal processes
neural regeneration
Schwann cells
glia
spinal cord
immunohistochemistry
allodynia
weight bearing
sciatic static index
walking track analysis
itch
SNARE
VAMP
mast cells
compound 48/80
chloroquine
spasticity
botulinum toxin type A
appropriate treatment
Therapeutic Index
pruritus
antipruritic
clinical
experimental
BoNT/A
astroglia
interleukins
microglia
TLR2
TLR4
Snap-23
pain
cerebral palsy
botulinum toxin A
complex regional pain syndrome
lumbar sympathetic ganglion block
chronic pelvic pain
overactive detrusor
vaginism
temporomandibular joint dislocation
lateral pterygoid muscle
botulinum toxin therapy
synaptic transmission
SNAP-25
epilepsy
Parkinson's disease
neurotransmission blockade
electrical activity
prion disease
new indications
formulation
delivery
refractory chronic migraine
tension headache
medication overuse headache
prophylactic treatment
XEOMIN®
BTX
central neuropathic pain
spinal cord injury
post-stroke shoulder pain
mouse test
Clostridium tetani
botulinum antitoxin
food safety
abobotulinumtoxinA
upper limb spasticity
post-stroke
early use
ONTIME
clinical trial
human
urodynamics
botulinum neurotoxin-A
basal ganglia
interspecies differences in motor behavior
mouse
rat
interneurons
hand tremor
treatment
electromyography
kinematics
essential tremor
dystonic tremor
tremor
movement disorders
Botulinum toxin
upper limb biomechanics
joint biomechanics
diagnostic guidance
clinical decision support
spastic paresis
electrical stimulation
stroke management
rehabilitation
hand
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Botulinum Neurotoxins and Nervous System
Record Nr. UNINA-9910557109003321
Luvisetto Siro  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Pathogenesis and Treatment of Chronic Pruritus
Pathogenesis and Treatment of Chronic Pruritus
Autore Kwatra Shawn G
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (144 p.)
Soggetto topico Medicine
Soggetto non controllato dupilumab
IL-4
IL-13
pruritus
chronic pruritus of unknown origin
prurigo nodularis
uremic pruritus
lichen planus
eosinophilic dermatosis of hematologic malignancy
chronic pruritus
mirtazapine
chronic
itch
refractory
treatment
noradrenergic
serotonergic
antihistaminergic
antidepressant
skin
atopic dermatitis
ceramide
pine tar
drug-induced
medication-related
epidemiology
inpatient
disease burden
national inpatient sample
medical dermatology
systematic review
prurigo
nodularis
atopic
dermatitis
race
gender
comorbidities
demographics
pediatric
children
malignancy
cancer
neoplasm
ion channels
cell signaling
Cav3.2 calcium channel
RT-PCR
wounds
itch in wounds
itch management
aprepitant
erlotinib
EGFR
epidermal growth factor receptor
NK1R
neurokinin1-receptor
mycosis fungoides
psoriasis
associations
lymphomatoid papulosis
lymphoma
racial differences
nodular prurigo
neuropathy
therapeutic
pathogenesis
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557104703321
Kwatra Shawn G  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui